INCYTE CORPORATION Other Current Liabilities
INCYTE CORPORATION (INCY) had Other Current Liabilities of $78.44 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-04-28
- 2026-03-31: Other Liabilities, Current $78.44M.
- 2025-12-31: Other Liabilities, Current $90.72M.
- 2025-09-30: Other Liabilities, Current $93.64M.
- 2025-06-30: Other Liabilities, Current $72.88M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $78.44M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $90.72M 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $93.64M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $72.88M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $74.52M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $58.87M 10-K · filed 2026-02-10 | |
| 2024-09-30 | $56.54M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $57.57M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $65.34M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $73.33M 10-K · filed 2025-02-10 | |
| 2023-09-30 | $90.60M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $86.27M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $129.92M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $68.43M 10-K · filed 2024-02-13 | $72.05M 10-K · filed 2023-02-07 |
| 2022-09-30 | $64.15M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $57.40M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $74.29M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $45.75M 10-K · filed 2023-02-07 | |
| 2021-09-30 | $74.65M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $58.94M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $76.68M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $35.11M 10-K · filed 2022-02-08 | $47.81M 10-K · filed 2021-02-09 |
| 2020-09-30 | $49.56M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $71.96M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $60.41M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $42.05M 10-K · filed 2021-02-09 | $42.02M 10-K · filed 2020-02-13 |
| 2019-09-30 | $53.61M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $47.40M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $39.91M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $34.57M 10-K · filed 2020-02-13 | |
| 2017-12-31 | $22.81M 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |